Delivery Order SPE2DB22D2108-SPE2DB24FU4MM

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
This federal contract award, valued at $1,014.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FAVX1) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S," a pharmaceutical product. The contract is a firm fixed-price arrangement with a performance period ending on May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, SPE2DX15D1022|SPE2DX25FVAMJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,781.24, is a Firm Fixed Price Delivery Order for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S," a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen Drug Corp holds a...
This federal contract award with ID SPE2DB22D2214|SPE2DB24FS5WP was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,381.37 firm-fixed-price delivery order is for the supply of the medical product "ESTROGEN-METHYLTESTOS F.S. TAB 100S." The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.12 firm-fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
This federal contract award, identified as SPE2DB22D1103|SPE2DB24FTHB6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of an estrogen-methyltestosterone medication in tablet form, with a ceiling value of $1,079.62 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, with a ceiling value of $1,444.13 and an ultimate completion date of April 4, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of pharmaceutical products, including Estrogen-Methyltestos F.S. tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,792.32 and a completion date of September 25, 2023. It is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with a set-aside requirement, indicating it...
This federal contract award, valued at $1,074.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of medical supplies, specifically "ESTROGEN-METHYLTESTOS H.S. TAB 100S", to support federal healthcare programs, including military treatment facilities and veteran's healthcare services. The contract is a delivery order with a firm fixed price, and it has a completion date of January 7,...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4MM
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2108|SPE2DB24FU4MM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, with a ceiling value of $2,296.49. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 19, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the military healthcare system. This award is part of the company's broader contract vehicles with the DLA, which include an Indefinite Delivery Contract valued up to $999,999,999 through December 2025 for a comprehensive range of medical commodities.

Generated 10/17/24, 9:13 AM